Key points are not available for this paper at this time.
GLP-1 RAs significantly reduce cardiovascular risk in high-risk T2DM patients, especially with combination therapy and in those with chronic kidney disease. However, further research is needed to confirm their long-term effects.
Building similarity graph...
Analyzing shared references across papers
Loading...
Xiaomei Chen
Xuge Zhang
Xiang Xiang
Diabetology & Metabolic Syndrome
Xian Yang Central Hospital
Dazhou Central Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Chen et al. (Sat,) studied this question.
www.synapsesocial.com/papers/696a9b70f6ea43690e0a154b — DOI: https://doi.org/10.1186/s13098-024-01497-4